ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,819, issued on June 2, was assigned to Icahn School of Medicine at Mount Sinai (New York).

"Compositions and methods for treating inflammatory bowel disease" was invented by Graham J. Britton (New York) and Jeremiah J. Faith (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods of diagnosing, treating, and monitoring the progression of inflammatory bowel disease in a subject, including, for example, by monitoring RORGammat+Th or RORGammat+Treg cell levels and treating the subject accordingly."

The patent was filed on Dec. 19, 2020, under Application No. 17/786,123.

*For further information, including images...